New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists

New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists Design, Synthesis, and Biological Evaluation of New 1,8-Naphthyridin-4(1H)-on-3-carboxamide and Quinolin-4(1H)-on-3-carboxamide Derivatives as CB₂Selective Agonists Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New CB₂Cannabinoid Receptors Agonists:  Synthesis, Pharmacological Properties and Molecular Modeling Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists Novel benzimidazole derivatives as selective CB2 agonists Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB₂Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1- f ][1,6]naphthyridines as CB 2 receptor antagonists/inverse agonists Conformational Restriction Leading to a Selective CB₂ Cannabinoid Receptor Agonist Orally Active Against Colitis